Abstract
A novel series of imidazolylpyrimidines were found to possess inhibitory activity against the human CMV UL70 primase. Extensive SAR studies on an HTS lead led to potent, orally bioavailable compounds with anti-CMV IC50 values of 150 nM in both viral yield and viral DNA replication assays and with a much reduced cytotoxicity compared to marketed treatments ganciclovir and cidofovir. © 2007 Elsevier Ltd. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Chen, X., Adrian, J., Cushing, T., DiMaio, H., Liang, L., Mayorga, V., … Jaen, J. (2007). SAR studies on a novel series of human cytomegalovirus primase inhibitors. Bioorganic and Medicinal Chemistry Letters, 17(8), 2188–2192. https://doi.org/10.1016/j.bmcl.2007.01.109
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
